Employment Type : Full-Time
The Role: As part of our vision, Moderna is committed to invest in R&D to further expand our impact on patients. We are building an independent research and business unit for genomic medicines, called Moderna Genomics (mGx) based in Technology Square, Cambridge, MA. mGx will be an innovation engine for the company focused on discovering and delivering the next generation of in vivo gene editing and non-viral gene therapies. It is our intention to be an industry leader in genomic medicines. Reporting to the Director of Quantitative Biology, the Scientist in Quantitative Biology for Moderna Genomics will be a key member of a high performing team developing next generation gene editing technology within Moderna Genomics. The Scientist will be an innovative and collaborative computational biologist with broad skills in the area of genomics. In collaboration with experimental scientists, he/she/they will develop and apply computational methods to analyze large-scale custom datasets generated by the team to discover transformative gene editing technologies. Here’s What You’ll Do: Create and implement custom bioinformatics data pipelines to analyze results from novel and established next-generation sequencing (NGS) assays Evaluate gRNA on-target/off-target effects Integrative analysis of internal data with public datasets Mine public datasets to generate novel hypothesis Here’s What You’ll Bring to the Table: A Ph.D. (or equivalent experience) in Computational Biology or another relevant field. Strong understanding of NGS techniques Experience in common bioinformatics tools for NGS data analysis and public databases Ability to work collaboratively Strong coding skills using Python, R Experience with high performance computing, preferably on public clouds (i.e. AWS, GCP, Azure) Here’s What We’ll Bring to the Table: Candidates should be aware that Moderna currently maintains a policy requiring all US-based employees to be fully vaccinated against COVID-19. Newly hired employees must be vaccinated prior to their employment start date. Moderna is an equal opportunity employer and will provide a reasonable accommodation to those unable to be vaccinated where it is not an undue hardship to the company to do so as provided under federal, state, and local law. About Moderna In 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna’s capabilities have come together to allow the authorized use of one of the earliest and most effective vaccines against the COVID-19 pandemic. Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years. To learn more, visit www.modernatx.com . Moderna is a smoke-free, alcohol-free and drug-free work environment. Moderna is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Moderna will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.